covista - CVSA

CVSA

Close Chg Chg %
127.74 -0.84 -0.66%

Pre-Market

126.90

-0.84 (0.66%)

Volume: 231.68K

Last Updated:

Oct 21, 2026, 3:59 PM EDT

Company Overview: covista - CVSA

CVSA Key Data

Open

$126.17

Day Range

125.92 - 127.95

52 Week Range

86.97 - 156.26

Market Cap

$4.35B

Shares Outstanding

33.86M

Public Float

32.88M

Beta

0.65

Rev. Per Employee

N/A

P/E Ratio

17.18

EPS

$7.63

Yield

0.00%

Dividend

$0.18

EX-DIVIDEND DATE

Nov 30, 2016

SHORT INTEREST

N/A

AVERAGE VOLUME

323.05K

 

CVSA Performance

1 Week
 
0.13%
 
1 Month
 
5.11%
 
3 Months
 
9.56%
 
1 Year
 
-17.03%
 
5 Years
 
244.89%
 

CVSA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 4
Full Ratings ➔

About covista - CVSA

Covista, Inc. engages in the provision of post-secondary education. It operates through the following segments: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. The Walden segment covers online certificates, bachelor's, master's, and doctoral degrees, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Medical and Veterinary segment includes degree and non-degree programs in the medical and veterinary postsecondary education industry. The company was founded by Dennis J. Keller and Ronald L. Taylor in 1973 and is headquartered in Chicago, IL.

CVSA At a Glance

Covista, Inc.
233 South Wacker Drive
Chicago, Illinois 60606
Phone 1-312-651-1400 Revenue 1.95B
Industry Other Consumer Services Net Income 267.38M
Sector Consumer Services 2026 Sales Growth 9.271%
Fiscal Year-end 06 / 2027 Employees 10,680
View SEC Filings

CVSA Valuation

P/E Current 17.175
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 16.652
Price to Sales Ratio 2.278
Price to Book Ratio 2.934
Price to Cash Flow Ratio 9.46
Enterprise Value to EBITDA 10.438
Enterprise Value to Sales 2.525
Total Debt to Enterprise Value 0.184

CVSA Efficiency

Revenue/Employee 182,966.76
Income Per Employee 25,035.112
Receivables Turnover 11.524
Total Asset Turnover 0.664

CVSA Liquidity

Current Ratio 1.093
Quick Ratio 1.093
Cash Ratio 0.709

CVSA Profitability

Gross Margin 60.282
Operating Margin 19.943
Pretax Margin 17.661
Net Margin 13.683
Return on Assets 9.089
Return on Equity 18.569
Return on Total Capital 11.37
Return on Invested Capital 11.925

CVSA Capital Structure

Total Debt to Total Equity 62.613
Total Debt to Total Capital 38.504
Total Debt to Total Assets 28.919
Long-Term Debt to Equity 59.854
Long-Term Debt to Total Capital 36.808
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Covista - CVSA

Collapse All in section
All values USD millions. 2023 2024 2025 2026 5-year trend
Sales/Revenue
1.45B 1.58B 1.79B 1.95B
Sales Growth
+4.59% +9.22% +12.85% +9.27%
Cost of Goods Sold (COGS) incl D&A
676.73M 681.02M 719.41M 776.12M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
151.28M 107.96M 84.47M 83.02M
Depreciation
90.05M 72.32M 73.25M 71.80M
Amortization of Intangibles
61.24M 35.64M 11.22M 11.22M
COGS Growth
-7.29% +0.63% +5.64% +7.88%
Gross Income
774.10M 903.63M 1.07B 1.18B
Gross Income Growth
+17.79% +16.73% +18.29% +10.21%
Gross Profit Margin
+53.36% +57.02% +59.77% +60.28%
2023 2024 2025 2026 5-year trend
SG&A Expense
557.77M 631.35M 722.64M 788.26M
Research & Development
- - - -
-
Other SG&A
557.77M 631.35M 722.64M 788.26M
SGA Growth
+12.02% +13.19% +14.46% +9.08%
Other Operating Expense
- - - -
-
Unusual Expense
61.48M 55.23M 4.70M 11.14M
EBIT after Unusual Expense
154.85M 217.05M 341.54M 378.57M
Non Operating Income/Expense
20.28M 10.54M 9.29M 7.18M
Non-Operating Interest Income
- 9.18M 8.22M 5.46M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
63.10M 63.66M 52.32M 40.63M
Interest Expense Growth
-51.22% +0.89% -17.82% -22.35%
Gross Interest Expense
63.10M 63.66M 52.32M 40.63M
Interest Capitalized
- - - -
-
Pretax Income
112.03M 163.94M 298.51M 345.12M
Pretax Income Growth
+348.61% +46.33% +82.09% +15.61%
Pretax Margin
+7.72% +10.35% +16.69% +17.66%
Income Tax
10.28M 26.22M 65.84M 77.74M
Income Tax - Current - Domestic
14.59M 14.73M 47.81M 2.14M
Income Tax - Current - Foreign
614.00K 419.00K (388.00K) 7.25M
Income Tax - Deferred - Domestic
(5.45M) 7.62M 16.08M 65.58M
Income Tax - Deferred - Foreign
530.00K 3.46M 2.33M 2.77M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
101.75M 137.71M 232.68M 267.38M
Minority Interest Expense
- - - -
-
Net Income
101.75M 137.71M 232.68M 267.38M
Net Income Growth
+441.14% +35.34% +68.96% +14.91%
Net Margin Growth
+7.01% +8.69% +13.01% +13.68%
Extraordinaries & Discontinued Operations
- - (4.82M) (936.00K)
-
Discontinued Operations
- - (4.82M) (936.00K)
-
Net Income After Extraordinaries
96.93M 136.78M 232.68M 267.38M
Preferred Dividends
- - - -
-
Net Income Available to Common
96.93M 136.78M 232.68M 267.38M
EPS (Basic)
2.1646 3.4704 6.2742 7.6295
EPS (Basic) Growth
+167.24% +60.33% +80.79% +21.60%
Basic Shares Outstanding
44.78M 39.41M 37.09M 35.05M
EPS (Diluted)
2.1258 3.3934 6.0697 7.4864
EPS (Diluted) Growth
+166.03% +59.63% +78.87% +23.34%
Diluted Shares Outstanding
45.60M 40.31M 38.33M 35.72M
EBITDA
367.62M 380.25M 430.70M 472.72M
EBITDA Growth
+6.28% +3.44% +13.27% +9.76%
EBITDA Margin
+25.34% +24.00% +24.08% +24.19%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 158.75
Number of Ratings 4 Current Quarters Estimate 2.395
FY Report Date 12 / 2026 Current Year's Estimate 9.045
Last Quarter’s Earnings 1.825 Median PE on CY Estimate N/A
Year Ago Earnings 8.25 Next Fiscal Year Estimate 10.005
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 4 4 4
Mean Estimate 2.40 2.59 9.05 10.01
High Estimates 2.52 2.70 9.09 10.19
Low Estimate 2.24 2.41 8.97 9.83
Coefficient of Variance 5.02 4.81 0.58 1.47

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 3 4
OVERWEIGHT 0 0 0
HOLD 1 1 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Buy

Insider Actions for Covista - CVSA

Date Name Shares Transaction Value
Oct 12, 2026 Stephen Wayne Beard Chairman & CEO 473,825 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $130.37 per share 61,772,565.25
Oct 12, 2026 Stephen Wayne Beard Chairman & CEO 469,158 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $130.77 per share 61,351,791.66
Mar 6, 2026 Michael William Malafronte Director 1,200 Open market or private purchase of non-derivative security Non-derivative transaction at $97.97 per share 117,564.00

Covista in the News